SGAM
Smith Group Asset Management Portfolio holdings
AUM
$1.53B
1-Year Return
38.67%
This Quarter Return
+16.25%
1 Year Return
+38.67%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$1.73B
AUM Growth
-$187M
(-9.7%)
Cap. Flow
-$411M
Cap. Flow
% of AUM
-23.77%
Top 10 Holdings %
Top 10 Hldgs %
38.99%
Holding
343
New
37
Increased
19
Reduced
205
Closed
33
Top Buys
| 1 |
Coherent
COHR
|
$25.7M |
| 2 |
Arrow Electronics
ARW
|
$19.8M |
| 3 |
Thermo Fisher Scientific
TMO
|
$15M |
| 4 |
DaVita
DVA
|
$13.1M |
| 5 |
International Paper
IP
|
$12.3M |
Top Sells
| 1 |
Apple
AAPL
|
$49.1M |
| 2 |
Microsoft
MSFT
|
$36.4M |
| 3 |
Amazon
AMZN
|
$29.2M |
| 4 |
Akamai
AKAM
|
$21.3M |
| 5 |
Centene
CNC
|
$21.3M |
Sector Composition
| 1 | Technology | 37.84% |
| 2 | Consumer Discretionary | 16.07% |
| 3 | Healthcare | 13.89% |
| 4 | Financials | 9.26% |
| 5 | Industrials | 8.02% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
RDFN
201
DELISTED
Redfin
RDFN
| $113K | 0.01% |
+1,650
| New | +$113K |
|
|
EGOV
202
DELISTED
NIC Inc
EGOV
| $112K | 0.01% |
+4,340
| New | +$112K |
|
|
BIG
203
DELISTED
Big Lots, Inc.
BIG
| $111K | 0.01% |
+2,580
| New | +$111K |
|
204
iShares Russell 1000 Growth ETF
IWF
$117B
| $106K | 0.01% |
+440
| New | +$106K |
|
|
CCXI
205
DELISTED
ChemoCentryx, Inc.
CCXI
| $102K | 0.01% |
1,650
| – | – |
|
|
GNMK
206
DELISTED
GenMark Diagnostics, Inc
GNMK
| $100K | 0.01% |
6,830
| – | – |
|
207
FibroGen
FGEN
$48.7M
| $88K | 0.01% |
95
| – | – |
|
|
FBM
208
DELISTED
Foundation Building Materials, Inc. Common Stock
FBM
| $87K | 0.01% |
4,550
-4,750
| -51% | -$90.8K |
|
209
Heron Therapeutics
HRTX
$199M
| $79K | ﹤0.01% |
3,720
| – | – |
|
210
Ironwood Pharmaceuticals
IRWD
$188M
| $78K | ﹤0.01% |
6,830
| – | – |
|
211
Xencor
XNCR
$612M
| $77K | ﹤0.01% |
1,760
| – | – |
|
212
Bank of America
BAC
$368B
| $62K | ﹤0.01% |
2,026
-69
| -3% | -$2.11K |
|
213
Citigroup
C
$176B
| $57K | ﹤0.01% |
917
-13
| -1% | -$808 |
|
214
Exxon Mobil
XOM
$466B
| $55K | ﹤0.01% |
1,338
-43,776
| -97% | -$1.8M |
|
215
Wells Fargo
WFC
$253B
| $54K | ﹤0.01% |
1,799
-12
| -0.7% | -$360 |
|
216
Blackrock
BLK
$171B
| $53K | ﹤0.01% |
73
-1
| -1% | -$726 |
|
217
Regenxbio
RGNX
$492M
| $52K | ﹤0.01% |
1,140
| – | – |
|
218
BHP
BHP
$138B
| $50K | ﹤0.01% |
863
-23
| -3% | -$1.33K |
|
219
Allogene Therapeutics
ALLO
$257M
| $49K | ﹤0.01% |
1,960
-10
| -0.5% | -$250 |
|
220
Inovio Pharmaceuticals
INO
$150M
| $48K | ﹤0.01% |
448
| – | – |
|
221
US Bancorp
USB
$76.1B
| $48K | ﹤0.01% |
1,023
-34
| -3% | -$1.6K |
|
222
Chevron
CVX
$310B
| $45K | ﹤0.01% |
529
-82,713
| -99% | -$7.04M |
|
223
PNC Financial Services
PNC
$80.6B
| $44K | ﹤0.01% |
295
-14
| -5% | -$2.09K |
|
224
Duke Energy
DUK
$93.8B
| $42K | ﹤0.01% |
81
| – | – |
|
225
TotalEnergies
TTE
$133B
| $40K | ﹤0.01% |
961
-25
| -3% | -$1.04K |
|